alpha-synuclein CSF
Selected indexed studies
- A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research. (Lancet Neurol, 2024) [PMID:38267190]
- CSF α-Synuclein and Tau as Biomarkers for Dementia With Lewy Bodies: A Systematic Review and Meta-analysis. (Alzheimer Dis Assoc Disord, 2022) [PMID:36183420]
- α-synuclein biomarker assays: bridging research and patient care. (Lancet Neurol, 2025) [PMID:40683277]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research. (2024) pubmed
- CSF α-Synuclein and Tau as Biomarkers for Dementia With Lewy Bodies: A Systematic Review and Meta-analysis. (2022) pubmed
- α-synuclein biomarker assays: bridging research and patient care. (2025) pubmed
- CSF α-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders. (2024) pubmed
- Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease. (2020) pubmed
- Association of CSF α-synuclein seed amplification assay positivity with disease progression and cognitive decline: A longitudinal Alzheimer's Disease Neuroimaging Initiative study. (2024) pubmed
- Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder. (2023) pubmed
- α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders. (2023) pubmed
- CSF α-Synuclein Seed Amplification Assays and Skin Immunofluorescence: Clinical Applications, Research Opportunities, and Knowledge Gaps. (2026) pubmed
- Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies. (2025) pubmed